Am J Surg Pathol

1. HAMMER PM, Wang A, Vermij L, Zdravkovic S, et al
   Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous Components.
   Am J Surg Pathol. 2024 May 23. doi: 10.1097/PAS.0000000000002250.
   

   >> Share

   
   
2. YOON JY, Sharma A, Ligon AH, Ramesh RG, et al
   Genomic Catastrophe (Chromothripsis and Polyploidy) Correlates With Tumor Distribution in Extrauterine High-grade Serous Carcinoma.
   Am J Surg Pathol. 2024;48:1017-1023.
   

   >> Share

   
   

   
   Br J Cancer

3. NAGLE CM, Ibiebele TI, Bandera EV, Cramer D, et al
   Pre-diagnosis tea and coffee consumption and survival after a diagnosis of ovarian cancer: results from the Ovarian Cancer Association Consortium.
   Br J Cancer. 2024 Jul 18. doi: 10.1038/s41416-024-02792.
   

   >> Share

   
   

   
   Clin Cancer Res

4. LORENTZEN GM, Laniewski P, Cui H, Mahnert ND, et al
   Cervicovaginal metabolome and tumor characteristics for endometrial cancer detection and risk stratification.
   Clin Cancer Res. 2024 Apr 30. doi: 10.1158/1078-0432.CCR-23-2934.
   

   >> Share

   
   

   
   Eur J Obstet Gynecol Reprod Biol

5. ABU-ZAID A, Baradwan S, Alyafi M, Al Baalharith M, et al
   Association between polycystic ovary syndrome and the risk of malignant gynecologic cancers (ovarian, endometrial, and cervical): A population-based study from the U.S.A. National Inpatient Sample 2016-2019.
   Eur J Obstet Gynecol Reprod Biol. 2024;299:283-288.
   

   >> Share

   
   

   
   Int J Cancer

6. 
   Correction to "Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer".
   Int J Cancer. 2024 Jun 21. doi: 10.1002/ijc.35059.
   

   >> Share

   
   

   
   Mol Ther Oncol

7. GEOFFROY K, Mullins-Dansereau V, Leclerc-Desaulniers K, Viens M, et al
   Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer.
   Mol Ther Oncol. 2024;32:200826.
   

   >> Share

   
   

   
   PLoS One

8. CARTER R, Petrik JJ, Moorehead RA
   Overexpression of miR-200s inhibits proliferation and invasion while increasing apoptosis in murine ovarian cancer cells.
   PLoS One. 2024;19:e0307178.
   

   >> Share

   
   
9. PATRA A, Ali SS, Devi NM, Qadeer AS, et al
   Prevalence of BRCA mutation in breast and ovarian cancer among women in India: A systematic review and meta-analysis protocol.
   PLoS One. 2024;19:e0306612.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share